] , “A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlus”, Arch Ophthalmol, vol. 127, no. 9, pp. 1101-14, 2009.
, “SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.”, Ophthalmology, vol. 116, no. 3, pp. 504-12, 2009.
, “SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion type.”, Ophthalmology, vol. 116, no. 4, pp. 756-61, 2009.
, “SCORE Study report 3: study design and baseline characteristics.”, Ophthalmology, vol. 116, no. 9, pp. 1770-1777.e1, 2009.
, “SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design.”, Am J Ophthalmol, vol. 148, no. 5, pp. 725-732.e7, 2009.
, “The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4.”, Arch Ophthalmol, vol. 127, no. 11, pp. 1461-7, 2009.
, “Influence of prior assignment on refusal rates in a trial of supplemental oxygen for retinopathy of prematurity.”, Paediatr Perinat Epidemiol, vol. 20, no. 4, pp. 348-59, 2006.
, “A pulmonary score for assessing the severity of neonatal chronic lung disease.”, Pediatrics, vol. 115, no. 4, pp. e450-7, 2005.
, “A new protocol for evaluating putative causes for multiple variables in a spatial setting, illustrated by its application to European cancer rates.”, Am J Hum Biol, vol. 16, no. 1, pp. 1-16, 2004.
, “Statistical issues related to early closure of STOP-ROP, a group-sequential trial.”, Control Clin Trials, vol. 24, no. 1, pp. 28-38, 2003.